Literature DB >> 522183

Propylthiouracil and hepatitis: a case report.

C M Reddy.   

Abstract

A 10-year-old girl initially presented with clinical features and thyroid function tests consistent with hyperthyroidism. She was treated with propylthiouracil, 100 mg, three times a day. She developed jaundice and hepatitis following treatment with propylthiouracil for 40 days. Clinical features of hepatitis improved after the discontinuation of propylthiouracil and she became euthyroid. At this time, an immunofluorescent technique revealed antibodies consistent with autoimmune thyroiditis. From this report, it appears that hepatitis is one of the infrequent complications of treatment with propylthiouracil and transient hyperthyroidism may be associated with autoimmune thyroiditis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 522183      PMCID: PMC2537460     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Letter: Hepatitis and propylthiouracil.

Authors:  L N Parker
Journal:  Ann Intern Med       Date:  1975-02       Impact factor: 25.391

2.  Propylthiouracil-induced agranulocytosis, toxic hepatitis, and death.

Authors:  A R COLWELL; D E SANDO; S J LANG
Journal:  J Am Med Assoc       Date:  1952-02-23

3.  Differentiation of chronic lymphocytic thyroiditis and simple goiter in pediatrics.

Authors:  J A Monteleone; R K Danis; K S Tung; C V Ramos; V H Peden
Journal:  J Pediatr       Date:  1973-09       Impact factor: 4.406

4.  Hyperthyroidism associated with histologic Hashimoto's thyroiditis.

Authors:  V Fatourechi; W M McConahey; L B Woolner
Journal:  Mayo Clin Proc       Date:  1971-10       Impact factor: 7.616

5.  Concurrence of Grave's disease and Hashimoto's thyroiditis.

Authors:  T Sato; I Takata; T Taketani; K Saida; H Nakajima
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

  5 in total
  4 in total

1.  Propylthiouracil-induced hepatotoxicity.

Authors:  J T Hardee; A L Barnett; A Thannoun; B Eghtesad; D Wheeler; M M Jamal
Journal:  West J Med       Date:  1996-09

Review 2.  Adverse immunologic effects of antithyroid drugs.

Authors:  S S Wing; I G Fantus
Journal:  CMAJ       Date:  1987-01-15       Impact factor: 8.262

3.  Propylthiouracil-associated hepatitis.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-01       Impact factor: 1.798

4.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.